Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)

References

• Papastergiou J, Zervas J, Li W, et al. Home medication reviews by community pharmacists: reaching out to homebound patients. Can Pharm J). 2013;146(3):139–142.
   Google Scholar
• Home Medication Review Protocol. In: Division PS, editor. 1st ed. Malaysia: Ministry of Health; 2011.
   Google Scholar
• Administrator PP. Program Rules Home Medicines Review. In: Health Do, editor. Australia: Australian Government; 2019.
   Google Scholar
• Gudi SK, Kashyap A, Chhabra M, et al. Impact of pharmacist-led home medicines review services on drug-related problems among the elderly population: a systematic review. Epidemiol Health. 2019;41:e2019020.
   PubMed Web of Science ®Google Scholar
• Einarson TR, Acs A, Ludwig C, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83.
   PubMed Web of Science ®Google Scholar
• Chandran A, Abdullah MN, Abdul F. National Diabetes Registry Report 2013–2019. In: Section NCD, editor. Malaysia: Ministry of Health; 2020.
   Google Scholar
• Mehmood S, Hasan SMF, Razzakova CM, et al. Abstracts from the 1st JoPPP Conference on Pharmaceutical Policy and Practice. J of Pharm Policy and Pract. 2020;13(S1):3.
   Google Scholar
• Thanimalai S, Shafie AA, Ahmad Hassali MA, et al. Cost-effectiveness of warfarin medication therapy adherence clinic versus usual medical clinic at Kuala Lumpur Hospital. Value Health Reg Issues. 2018;15:34–41.
   PubMedGoogle Scholar
• CCEMG - EPPI-Centre Cost Converter. 2019. [cited 23 Sep 2020]. Available from: https://eppi.ioe.ac.uk/costconversion/default.aspx
   Google Scholar
• Service lines and activity-based costing reveal true cost of care for UPMC [Internet]. Health Catalyst. 2016. [cited 20 Jun 2019]. Available from: https://www.healthcatalyst.com/success_stories/activity-based-costing-in-healthcare-upmc
   Google Scholar
• Michalska J, Szewieczek D. The improvement of the quality management by the activity-based costing. J Achiev Mater Manuf Eng. 2007;21(1):91–94.
   Google Scholar
• Ramsey SD, Willke RJ, Glick H, et al. Cost-effectiveness analysis alongside clinical trials II-an ISPOR good research practices task force report. Value Health. 2015;18(2):161–172.
   PubMed Web of Science ®Google Scholar
• Indeks jadual gaji minimum-maksimum perkhidmatan awam Malaysia [Malaysian public service minimum-maximum salary schedule index]. In: Malaysia JPA, Government of Malaysia. Malaysia; 2016.
   Google Scholar
• Average retail pharmacist salary [Internet]. PayScale, Inc. 2019. [cited 23 Dec 2019]. Available from: https://www.payscale.com/research/MY/Job=Pharmacist/Salary
   Google Scholar
• Fees (Medical) (Amendment) order [Internet]. Attorney General's Chamber. 2017. [cited 27 Nov 2019]. Available from: https://docplayer.net/55666838-Perintah-fi-perubatan-pindaan-2017-fees-medical-amendment-order-2017.html
   Google Scholar
• Fees (Medical)(Cost of Services) order [Internet]. Attorney General's Chamber 2014. [cited 27 Nove 2019]. Available from: http://www.federalgazette.agc.gov.my/outputp/pua_20141231_P.U.%20(A)%20363_Perintah%20Fi%20(Perubatan)%20(Kos%20Perkhidmatan)%202014.pdf
   Google Scholar
• Shafie AA, Vasan Thakumar A, Lim CJ, et al. EQ-5D-5L valuation for the Malaysian population. Pharmacoeconomics. 2019;37(5):715–725.
   PubMed Web of Science ®Google Scholar
• Doshi JA, Glick HA, Polsky D. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials. Value Health. 2006;9(5):334–340.
   PubMed Web of Science ®Google Scholar
• Nixon RM, Wonderling D, Grieve RD. Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared. Health Econ. 2010;19(3):316–333.
   PubMed Web of Science ®Google Scholar
• Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997;6(4):327–340.
   PubMed Web of Science ®Google Scholar
• Savitz LA, Savitz ST. Can delivery systems use cost-effectiveness analysis to reduce healthcare costs and improve value. F1000Res. 2016;5:2575.
   Google Scholar
• Lim YW, Shafie AA, Chua GN, et al. Determination of cost-effectiveness threshold for health care interventions in Malaysia. Value Health. 2017;20(8):1131–1138.
   PubMed Web of Science ®Google Scholar
• Saha S, Gerdtham UG, Johansson P. Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Public Health. 2010;7(8):3150–3195.
   PubMed Web of Science ®Google Scholar
• Abridged life tables, Malaysia, 2015–2017 [Internet]. Department of Statistics, Malaysia. 2017. [cited 18 Nov 2019]. Available from: https://www.dosm.gov.my/v1/index.php?r=column/pdfPrev&id=dkdvKzZ0K1NiemEwNlJteDBSUGorQT09
   Google Scholar
• The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56) [Internet]. University of Oxford. 2001. [cited 20 Apr 2020]. Available from: https://www.dtu.ox.ac.uk/riskengine/ukpds56.pdf
   Google Scholar
• Shafie AA, Ng CH. Cost-effectiveness of insulin glargine and insulin detemir in the basal regimen for naïve insulin patients with type 2 diabetes mellitus (T2DM) in Malaysia. Clinicoecon Outcomes Res. 2020;12:333–343.
   PubMed Web of Science ®Google Scholar
• Abridged life tables, Malaysia, 2016–2018. [Internet]. Department of Statistics Malaysia. 2018. [cited 20 Feb 2020]. Available from: https://www.dosm.gov.my/v1/index.php?r=column/pdfPrev&id=aDV6TWxoU0NlNVBYN1hXM1Y0L2Jadz09
   Google Scholar
• Consumer price index Malaysia February 2020 [Internet]. Department of Statistics. 2020. [cited 14 Apr 2020]. Available from: https://www.dosm.gov.my/v1/index.php?r=column/pdfPrev&id=MFc0djV4akVKUlVUVU4ydVRDSE9PZz09
   Google Scholar
• Pharmacoeconomic Guidelines for Malaysia 2nd edition [Internet]. Ministry of Health. 2019. [cited 28 Jun 2020]. Available from: https://www.pharmacy.gov.my/v2/sites/default/files/document-upload/pharmacoeconomic-guidelines-malaysia-malaysia-second-edition-2019-final-page-adjustment.pdf
   Google Scholar
• Wannamethee SG, Shaper AG, Whincup PH, et al. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med. 2011;171(5):404–410.
   PubMedGoogle Scholar
• Dennis MS, Burn JPS, Sandercock PAG, et al. Long-term survival after first-ever stroke: the oxfordshire community stroke project. AHA J. 1993;24(6):796–800.
   Google Scholar
• Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229–234.
   PubMed Web of Science ®Google Scholar
• Alias NEB. The impact of home medication review in patients with type 2 diabetes mellitus living in rural areas of kuantan [master’s thesis]. Malaysia: International Islamic University Malaysia; 2015.
   Google Scholar
• Chow EP, Hassali MA, Saleem F, et al. Effects of pharmacist-led patient education on diabetes-related knowledge and medication adherence: A home-based study. Health Educ J. 2016;75(4):421–433.
   Web of Science ®Google Scholar
• Jokanovic N, Tan EC, Sudhakaran S, et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Social Adm Pharm. 2017;13(4):661–685.
   PubMed Web of Science ®Google Scholar
• Yu J, Shah BM, Ip EJ, et al. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from kaiser permanente northern california. JMCP. 2013;19(2):102–114.
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412.
   PubMed Web of Science ®Google Scholar
• Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43(2):173–184.
   Google Scholar
• Tinelli M, White J, Manfrin A. novel pharmacist-led intervention secures the minimally important difference (MID) in Asthma Control Test (ACT) score: better outcomes for patients and the healthcare provider. BMJ Open Resp Res. 2018;5(1):e000322.
   PubMed Web of Science ®Google Scholar
• Li R, Zhang P, Barker LE, et al. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33(8):1872–1894.
   PubMed Web of Science ®Google Scholar
• Franz MJ, Splett PL, Monk A, et al. Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non–insulin-dependent diabetes mellitus. J Am Diet Assoc. 1995;95(9):1018–1024.
   PubMedGoogle Scholar
• Odnoletkova I, Ramaekers D, Nobels F, et al. Delivering diabetes education through nurse-led telecoaching. Cost-effectiveness analysis. PLOS One. 2016;11(10):e0163997.
   PubMed Web of Science ®Google Scholar
• Belgium GDP [Internet]. Trading Economic. 2016. [cited 25 Jun 2020]. Available from: https://tradingeconomics.com/belgium/gdp-per-capita
   Google Scholar
• Bosmans JE, van der Laan DM, Yang Y, et al. The cost-effectiveness of an intervention program to enhance adherence to antihypertensive medication in comparison with usual care in community pharmacies. Front Pharmacol. 2019;10:210.
   PubMed Web of Science ®Google Scholar
• Wallerstedt SM, Bladh L, Ramsberg J. A cost-effectiveness analysis of an in-hospital clinical pharmacist service. BMJ Open. 2012;2:e000329.
   PubMed Web of Science ®Google Scholar
• Pettitt DA, Raza S, Naughton B, et al. The limitations of QALY: a literature review. J Stem Cell Res Ther. 2016;06(04):334
   Google Scholar
• Knapp M, Mangalore R. The trouble with QALYs. Epidemiol Psichiatr Soc. 2007;16(4):289–293.
   PubMedGoogle Scholar
• Garau M, Shah KK, Mason AR, et al. Using QALYs in cancer: a review of the methodological limitations. Pharmacoeconomics. 2011;29(8):673–685.
   PubMed Web of Science ®Google Scholar
• Wilson PWF, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. AHA J. 1998;97(18):1837–1847.
   Google Scholar
• Garrison LP, Mansley EC, Abbott TA, et al. Good research practices for measuring drug costs in cost-effectiveness analyses:a societal perspective: the ISPOR drug cost task force report—part II. ISPOR. 2010;13(1):8–13.
   PubMed Web of Science ®Google Scholar
• Gage BF, Cardinalli AB, Albers GW, et al. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 1995;274(23):1839–1845.
   PubMed Web of Science ®Google Scholar
• Lampe FC, Whincup PH, Wannamethee SG, et al. The natural history of prevalent ischaemic heart disease in middle-aged men. Eur Heart J. 2000;21(13):1052–1062.
   PubMed Web of Science ®Google Scholar
• Brennan VK, Mauskopf J, Colosia AD, et al. Utility estimates for patients with Type 2 diabetes mellitus after experiencing a myocardial infarction or stroke: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(1):111–123.
   PubMed Web of Science ®Google Scholar
• Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making. 2002;22(4):340–349.
   PubMed Web of Science ®Google Scholar
• Lee KY, Wan Ahmad WA, Low EV, et al. Comparison of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Malaysia: a cross sectional study. PLoS One. 2017;12(9):e0184410.
   PubMed Web of Science ®Google Scholar
• Aznida FAA, Azlin NMN, Amrizal MN, et al. The cost of treating an acute ischaemic stroke event and follow-up at a teaching hospital in Malaysia: a casemix costing analysis. BMC Health Services Research 2012;12(1):P6.
   PubMed Web of Science ®Google Scholar